A thousand words about the imaging in cardiac amyloidosis

  • Rafał Dankowski Poznań University of Medical Sciences
  • Marek Leszniewski
  • Małgorzata Pyda
  • Andrzej Szyszka
Keywords: amyloidosis, echocardiography, myocardial strain imaging, cardiac magnetic resonance

Abstract

Cardiac amyloidosis is an infiltrative disease which usually occurs under the form of restrictive cardiomyopathy. Advances in the treatment have changed the unfavorable outcomes of this disease. Thus, early diagnosis is essential. Recent advances in echocardiography and cardiac magnetic resonance provided new modalities for the detection of cardiac amyloidosis. This summary discusses the role of imaging techniques in the diagnosis of cardiac amyloidosis.

References

Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. 2015 Nov-Dec;24(6):343-50.

Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, Sekijima Y, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 2018 Dec;25(4):215-9.

Sipe JD, Benson MD, Buxbaum JN, Ikeda S-i, Merlini G, Saraiva MJM, et al. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 2014 2014/12/01;21(4):221-4.

Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. The New England journal of medicine. 1997 Feb 13;336(7):466-73.

Rapezzi C, Quarta CC, Obici L, Perfetto F, Longhi S, Salvi F, et al. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. European heart journal. 2013 Feb;34(7):520-8.

Pinney JH, Smith CJ, Taube JB, Lachmann HJ, Venner CP, Gibbs SD, et al. Systemic amyloidosis in England: an epidemiological study. British journal of haematology. 2013 May;161(4):525-32.

González-López E, Dominguez F, Alonso-Pulpon L, Cobo-Marcos M, Garcia-Pavia P, Lara-Pezzi E, et al. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths. European heart journal. 2017;38(24):1895-904.

Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM, et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart failure. 2014 Apr;2(2):113-22.

Castano A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. European heart journal. 2017 Oct 7;38(38):2879-87.

Morner S, Hellman U, Suhr OB, Kazzam E, Waldenstrom A. Amyloid heart disease mimicking hypertrophic cardiomyopathy. Journal of internal medicine. 2005 Sep;258(3):225-30.

Falk RH. Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end? European heart journal. 2019;40(12):1009-12.

Picano E, Pinamonti B, Ferdeghini E, Landini L, Slavich G, Orlandini A, et al. Two-Dimensional Echocardiography in Myocardial Amyloidosis. Echocardiography. 1991;8(2):253-9.

Cacciapuoti F. The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis. Journal of echocardiography. 2015 Sep;13(3):84-9.

Di Nunzio D, Recupero A, de Gregorio C, Zito C, Carerj S, Di Bella G. Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging. Current cardiology reports. 2019 Feb 12;21(2):7.

Lang RM, Badano LP, Mor-avi V, Afilalo J, Armstrong A. Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2015 2015/01/01/;28(1):1-39.

Bellavia D, Abraham TP, Pellikka PA, Al-Zahrani GB, Dispenzieri A, Oh JK, et al. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2007 Oct;20(10):1194-202.

Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart (British Cardiac Society). 2012 Oct;98(19):1442-8.

Phelan D, Collier P, Thavendiranathan P, Popović ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart (British Cardiac Society). 2012;98(19):1442-8.

Marwick TH, Shah SJ, Thomas JD. Myocardial Strain in the Assessment of Patients With Heart Failure: A Review. JAMA cardiology. 2019 Feb 27.

Sun JP, Stewart WJ, Yang XS, Donnell RO, Leon AR, Felner JM, et al. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. The American journal of cardiology. 2009 Feb 1;103(3):411-5.

Pagourelias ED, Duchenne J, Mirea O, Vovas G, Van Cleemput J, Delforge M, et al. The Relation of Ejection Fraction and Global Longitudinal Strain in Amyloidosis: Implications for Differential Diagnosis. JACC: Cardiovascular Imaging. 2016 2016/11/01/;9(11):1358-9.

Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005 Jan 18;111(2):186-93.

Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, et al. Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis. JACC: Cardiovascular Imaging. 2010 2010/02/01/;3(2):155-64.

Fontana M, Banypersad SM, Treibel TA, Maestrini V, Sado DM, White SK, et al. Native T1 mapping in transthyretin amyloidosis. JACC Cardiovascular imaging. 2014 Feb;7(2):157-65.

Dungu JN, Valencia O, Pinney JH, Gibbs SD, Rowczenio D, Gilbertson JA, et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovascular imaging. 2014 Feb;7(2):133-42.

Published
2019-04-03
How to Cite
Dankowski, R., Leszniewski, M., Pyda, M., & Szyszka, A. (2019). A thousand words about the imaging in cardiac amyloidosis. Journal of Medical Science. https://doi.org/10.20883/jms.350
Section
Thousand words about...